From Experimentation to Innovation to Standard of Care (Video)

Plasma-Modified ACT Can Be Used to Monitor Bivalirudin (Angiomax) Anticoagulation for On-Pump Cardiopulmonary Bypass Surgery in a Patient with Heparin-Induced Thrombocytopenia

We report here the successful use of bivalirudin anticoagulation on pump, with no additional morbidity, and the first reported use of the plasma-modified ACT (activated clotting time) test, a simple modification of the standard ACT assay, to monitor the anticoagulant effect of bivalirudin.

Process Improvement in Cardiac Surgery: Development and Implementation of a Reoperation for Bleeding Checklist

Hence, our primary objective was to develop and implement a formal operative checklist to reduce technical reasons for postoperative bleeding.